Mitochondrial electron transport chain complex III sustains hepatitis E virus replication and represents an antiviral target
Open Access
- 2 August 2018
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 33 (1) , 1008-1019
Abstract
Hepatitis E virus (HEV) infection has emerged as a global health problem. However, no approved medication is available, and the infection biology remains largely elusive. Electron transport chain (ETC), a key component of the mitochondria, is the main site that produces ATP and reactive oxygen species (ROS). By profiling the role of the different complexes of the mitochondrial ETC, we found that pharmacological inhibition of complex III, a well‐defined drug target for the treatment of malaria and Pneumocystis pneumonia, potently restricts HEV replication. This effect demonstrated in our HEV models is equivalent to the anti‐HEV potency of ribavirin, a widely used off‐label treatment for patients with chronic HEV. Mechanistically, we found that this effect is independent of ATP production, ROS level, and pyridine depletion. By using pharmacological inhibitors and genetic approaches, we found that mitochondrial permeability transition pore (MPTP), a newly identified component of ETC, provides basal defense against HEV infection. HEV interferes with the opening of the MPTP. Furthermore, inhibition of the MPTP attenuated the anti‐HEV effect of complex III inhibitors, suggesting that the MPTP mediates the antiviral effects of these inhibitors. These findings reveal new insights on HEV–host interactions and provide viable anti‐HEV targets for therapeutic development.—Qu, C., Zhang, S., Wang, W., Li, M., Wang, Y., van der Heijde‐Mulder, M., Shokrollahi, E., Hakim, M. S., Raat, N. J. H., Peppelenbosch, M. P., Pan, Q. Mitochondrial electron transport chain complex III sustains hepatitis E virus replication and represents an antiviral target. FASEB J. 33, 1008–1019 (2019). www.fasebj.orgKeywords
Funding Information
- Maag Lever Darm Stichting (CDG 1304)
- KWF Kankerbestrijding (10140)
- National Natural Science Foundation of China (31770186)
- China Scholarship Council (201509110121, 201303250056, 201506100033)
This publication has 49 references indexed in Scilit:
- Nucleoside analogue 2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirinArchives of Virology, 2017
- Hepatitis E virus persists in the presence of a type III interferon responsePLOS Pathogens, 2017
- Hepatitis E virus ORF3 is a functional ion channel required for release of infectious particlesProceedings of the National Academy of Sciences, 2017
- Impact of hepatitis B virus infection on hepatic metabolic signaling pathwayWorld Journal of Gastroenterology, 2016
- A Mutation in the Hepatitis E Virus RNA Polymerase Promotes Its Replication and Associates With Ribavirin Treatment Failure in Organ Transplant RecipientsGastroenterology, 2014
- Calcineurin Inhibitors Stimulate and Mycophenolic Acid Inhibits Replication of Hepatitis E VirusGastroenterology, 2014
- Interactions Between Hepatitis C Virus and Mitochondria: Impact on Pathogenesis and Innate ImmunityCurrent Pathobiology Reports, 2013
- Adaptation of a Genotype 3 Hepatitis E Virus to Efficient Growth in Cell Culture Depends on an Inserted Human Gene Segment Acquired by RecombinationJournal of Virology, 2012
- The Mechanism of Superoxide Production by the Antimycin-inhibited Mitochondrial Q-cycleJournal of Biological Chemistry, 2011
- Hepatitis C Virus Triggers Mitochondrial Permeability Transition with Production of Reactive Oxygen Species, Leading to DNA Damage and STAT3 ActivationJournal of Virology, 2006